Page results
-
As an organisation, UCLH needs to minimise the environmental impact of our buildings and the energy they use and maximise our use of any technology available to support these changes. This page outlines our progress to date.
-
A UCLH patient with a rare hormonal condition is the first in the world to receive a new investigational drug in a first-in-human trial.
-
We provide routine histopathological diagnoses using both standard techniques and advanced diagnostics including immunocytochemistry, fluoresent in-situ hybridisation (FISH), and polymerase chain…
-
This page offers ways you can help us to prevent infection and make your babies safer.
-
Overall, most women (over 90%) spontaneously give birth to their baby after 37 weeks of pregnancy, called term delivery. Approximately 10%, or 1 in 10 women spontaneously give birth to their baby…
-
This page has been written to provide information to those women who choose to decline a blood transfusion or blood products. It is important for you to know that your decision is respected and that…
File results
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0262 - Clinical trial participation
-
FOI/2023/0275 - Trust statistics on spiking
-
FOI2017133 IT strategy/bussiness plan
-
FOI2017129 Water hygiene
-
FOI2017126 Staff infected by blood-borne virus by patients
-
FOI2017119 Diagnosis and treatment of Alzheimer disease patients
-
FOI2017115 Publications relating to learning from complaints, claims, incidents, serious incidents, events and inquests
-
FOI2017117 Freedom of Information Act requests
-
FOI/2023/0180 - Treatment guidelines for chronic kidney disease/ diabetic kidney disease